- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
NCCN adds two NHL subtypes to standard treatment guidelines
The newest National Comprehensive Cancer Network (NCCN) Guidelines for Non-Hodgkin’s Lymphomas (NHL) will include new treatment guidelines for a pair of diseases along with modifications to other guidelines.
Specifically, the guidelines will include new guidelines for treating two lymphoid leukemia subtypes:
- Hairy cell leukemia
- T-cell prolymphocytic leukemia
"These are rare diseases, but they do occur and there are effective treatments for both," said Andrew D. Zelenetz, MD, PhD, Department of Medicine Vice Chair of Medical Informatics at Memorial Sloan-Kettering Cancer Center. "The fact that they are so low in incidence makes the need for guidelines on appropriate management even more important.”
The new guidelines will also include changes to the guidelines for immunophenotyping and genetic testing in the diagnosis of non-Hodgkin's lymphoma.